İsrail - İbranice - Ministry of Health

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

İsrail - İbranice - Ministry of Health

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 0.64 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

İsrail - İbranice - Ministry of Health

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 1.28 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

İsrail - İbranice - Ministry of Health

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers.vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

İsrail - İbranice - Ministry of Health

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

İsrail - İbranice - Ministry of Health

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

İsrail - İbranice - Ministry of Health

astra zeneca israel ltd - vandetanib 100 mg - film coated tablets - vandetanib - caprelsa is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (mtc) in patients with unresectable locally advanced or metastatic disease. for patients in whom rearranged during transfection (ret) mutation is not known or is negative, a possible lower benefit should be taken into account before individual treatment decision

İsrail - İbranice - Ministry of Health

astra zeneca israel ltd - vandetanib 300 mg - film coated tablets - vandetanib - caprelsa is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (mtc) in patients with unresectable locally advanced or metastatic disease. for patients in whom rearranged during transfection (ret) mutation is not known or is negative, a possible lower benefit should be taken into account before individual treatment decision

İsrail - İbranice - Ministry of Health

astra zeneca (israel) ltd - fulvestrant - תמיסה להזרקה - fulvestrant 250 mg / 5 ml - fulvestrant - fulvestrant - faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.

İsrail - İbranice - Ministry of Health

astra zeneca (israel) ltd - fulvestrant - תמיסה להזרקה - fulvestrant 250 mg / 5 ml - fulvestrant - fulvestrant - faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.06/06/2010 בקשה לשינוי משטר מינון the recommended dose is 500 mg at intervals of one month, with an additional 500 mg dose given two weeks after the initial dose.